Vieceli et al. | Nakakubo et al. | Tordjman et al. | Aldobyany et al. | Kurstjen et al | |
---|---|---|---|---|---|
Vieceli et al. | ICC I95CI%): 0.43 (0.38–0.47) | ICC (95CI%): 0.37 (0.32–0.41) | ICC (95CI%): 0.17 (0.13–0.22) | ICC (95CI%): 0.61 (0.58–0.65) | |
Nakakubo et al. | MD ± LOA: 0.00 ± 2.10 | ICC (95CI%): 0.38 (0.35–0.43) | ICC (95CI%): 0.16 (0.12–0.21) | ICC (95CI%): 0.44 (0.40–0.48) | |
Tordjman et al. | MD ± LOA: 0.00 ± 2.20 | MD ± LOA: 0.00 ± 2.17 | ICC (95CI%): 0.10 (0.055–0.15) | ICC (95CI%): 0.46 (0.43–0.50) | |
Aldobyany et al. | MD ± LOA: 0.00 ± 2.52 | MD ± LOA: 0.00 ± 2.53 | MD ± LOA: 0.00 ± 2.62 | ICC (95CI%): 0.17 (0.12–0.22) | |
Kurstjen et al. | MD ± LOA: 0.00 ± 1.72 | MD ± LOA: 0.00 ± 2.08 | MD ± LOA: 0.00 ± 2.03 | MD ± LOA: 0.00 ± 2.53 |